Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01439581
Other study ID # Interface Pressure Mapping
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2011
Est. completion date September 2012

Study information

Verified date September 2019
Source Henry Ford Health System
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To determine if a device that measures and displays pressure that the patients feel when in bed can help nurses reposition the patient effectively and thereby reduce bedsores in the intensive care unit.


Recruitment information / eligibility

Status Completed
Enrollment 428
Est. completion date September 2012
Est. primary completion date October 2011
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years and older,

- care giver trained on mapping system

Exclusion Criteria:

- Less than 18 years,

- pregnant women,

- weight greater 550 lbs, and subjects requiring a specialty mattress

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Mapping System
Pressure Sensing coverlet on ICU bed and provides real time feedback to assist in effective patient repositioning
Non-Mapping System
Standard ICU bed with no mapping system

Locations

Country Name City State
United States Henry Ford Hospital Detroit Michigan

Sponsors (2)

Lead Sponsor Collaborator
Henry Ford Health System Wellsense USA Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pressure Mapping Reducing Hospital Acquired Pressure Ulcers Comparing number of pressure ulcers when using pressure mapping compared to when not. Time admitted in the Medical Intensive Care Unit
See also
  Status Clinical Trial Phase
Completed NCT01214811 - Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing Phase 3
Terminated NCT00700154 - Insulin Infusion Diabetes Ulcer N/A
Completed NCT01138436 - A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers Phase 2
Completed NCT01548378 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia Phase 2
Completed NCT01942941 - Peripheral Vascular Disease and Nerve Stimulation N/A
Completed NCT00718978 - Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS) N/A
Completed NCT00951080 - SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds N/A
Suspended NCT00701974 - Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers Phase 2/Phase 3
Completed NCT01474109 - Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients Phase 3
Terminated NCT01474122 - Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients Phase 3
Completed NCT00597818 - Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury Phase 2
Completed NCT00189540 - Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers Phase 2
Recruiting NCT04275323 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1) Phase 3
Completed NCT04274049 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2) Phase 3
Completed NCT00688428 - Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination Phase 1